Wisr AI Systems Inc. (CSE:WISR)

Oncternal Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023
Cash & Equivalents	1.31	0.16	0.1
Cash & Short-Term Investments	1.31	0.16	0.1
Cash Growth	1254.78%	71.13%	-
Other Receivables	0.02	0.01	0.14
Receivables	0.02	0.01	0.14
Prepaid Expenses	0	0	0
Total Current Assets	1.33	0.18	0.24
Total Assets	1.33	0.18	0.24
Accounts Payable	0.19	0.27	0.31
Short-Term Debt	-	-	0.08
Other Current Liabilities	-	0.12	0.12
Total Current Liabilities	0.27	0.39	0.51
Total Liabilities	0.27	0.39	0.51
Common Stock	9.07	7.03	7.04
Additional Paid-In Capital	0.09	0.01	-
Retained Earnings	-8.28	-7.42	-7.31
Comprehensive Income & Other	0.18	0.16	-
Shareholders' Equity	1.06	-0.22	-0.27
Total Liabilities & Equity	1.33	0.18	0.24
Total Debt	-	-	0.08
Net Cash (Debt)	1.31	0.16	0.02
Net Cash Growth	6026.36%	673.83%	-
Net Cash Per Share	0.03	0.00	0.00
Filing Date Shares Outstanding	50.97	34.69	29.48
Total Common Shares Outstanding	49.83	34.69	29.48
Working Capital	1.06	-0.22	-0.27
Book Value Per Share	0.02	-0.01	-0.01
Tangible Book Value	1.06	-0.22	-0.27
Tangible Book Value Per Share	0.02	-0.01	-0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.